Chemoinformaics analysis of Gelsempervine A
Molecular Weight | 382.46 | nRot | 2 |
Heavy Atom Molecular Weight | 356.252 | nRig | 24 |
Exact Molecular Weight | 382.189 | nRing | 4 |
Solubility: LogS | -3.396 | nHRing | 2 |
Solubility: LogP | 2.8 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 4 | No. of Arom Bond | 10 |
nHA | 5 | APOL | 59.4846 |
nHD | 2 | BPOL | 31.8354 |
QED | 0.615 |
Synth | 4.844 |
Natural Product Likeliness | 1.896 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.076 |
Pgp-sub | 0.019 |
HIA | 0.073 |
CACO-2 | -4.639 |
MDCK | 0.0000118 |
BBB | 0.975 |
PPB | 0.755152 |
VDSS | 1.384 |
FU | 0.363752 |
CYP1A2-inh | 0.713 |
CYP1A2-sub | 0.594 |
CYP2c19-inh | 0.137 |
CYP2c19-sub | 0.905 |
CYP2c9-inh | 0.038 |
CYP2c9-sub | 0.535 |
CYP2d6-inh | 0.909 |
CYP2d6-sub | 0.875 |
CYP3a4-inh | 0.586 |
CYP3a4-sub | 0.763 |
CL | 11.522 |
T12 | 0.189 |
hERG | 0.012 |
Ames | 0.048 |
ROA | 0.964 |
SkinSen | 0.112 |
Carcinogencity | 0.952 |
EI | 0.012 |
Respiratory | 0.988 |
NR-Aromatase | 0.175 |
Antiviral | Yes |
Prediction | 0.658081 |